Phibro Animal Health Corporation (PAHC) stock analysis
PAHC · Phibro Animal Health Corporation
Latest recorded price: USD 35.02
Model-estimated fair value: USD 43.48. This assumption-based estimate is for general research and is not investment advice.
Sector and industry: Healthcare · Drug Manufacturers - Specialty & Generic
At $35.02, PAHC trades 19.5% below the model's base-case value of $43.48. Using Operating FCFF DCF (revenue x margin - reinvestment), the model estimates $30.08 in the conservative case and $60.38 in the optimistic case, with a valuation confidence score of 45/100. About 95% of the value comes from the terminal value, so the result is sensitive to long-term growth and discount-rate assumptions. Fiscal 2026 figures: revenue growth 15.8%, free cash flow margin 0.6%, ROIC 16.2%. The model flags 2 risk signals for this company (1 high severity).